The ACP has been acquired by PSA
The Pharmaceutical Society of Australia’s (PSA) acquisition of the Australasian College of Pharmacy (ACP) formally settled on 19 December 2025.
The acquisition means a strengthened PSA can scale products and services members value most, by reducing duplication and investing more in education, practice support, and advocacy, without changing PSA’s peak body mandate.
Both organisations have now entered a structured transition phase, which will be implemented throughout 2026. The priority will be to minimise disruption, so services currently delivered to members, learners, and stakeholders will continue without interruption during the transition.
What it means for the ACP and PSA
Following PSA’s acquisition of the ACP, PSA will be better positioned to:
- invest in education and professional development
- improve consistency and quality of member services
- prioritise initiatives that members of both organisations have consistently identified as high value through consultation and feedback
- provide clearer pathways for learners
- sustainably invest in future programs
- reduce administrative overheads
- create long-term organisational stability.

